Effective strategies involve regular reassessment of risk factors, blood pressure and lipid management, smoking cessation, and the use of sodium-glucose cotransporter-2 (SGLT2) inhibitors or GLP-1 RAs
[DOI] [PubMed] [Google Scholar] 100.Jeon Y., Yoon J.D., Cai L., Hwang S.-U., Kim E., Zheng Z., Lee E., Kim D.Y., Hyun S.-H
In a 48-week Phase 2 study published in The New England Journal of Medicine, subjects receiving the highest dose of retatrutide (12 mg) showed a mean percentage change in body weight that exceeded the 24% mark
GLP-1R-targeted nanoplatforms are particularly well-suited to such customization due to their modular design and the availability of organ-specific targeting ligands
Change (rotate) your injection site with each injection